herbicide

June 9, 2022

Bayer wins latest Roundup cancer trial; tied 3-to-3 with plaintiffs for court wins

A Kansas City, Mo., jury on Thursday dismissed claims by a man who blamed his cancer on exposure to Monsanto’s Roundup herbicide, agreeing with the company that the weed killer was not the source of the man’s disease.

The conclusion of the month-long trial gives Monsanto owner Bayer three courtroom wins in a row and brings the nationwide litigation battle to a 3-to-3 tie: the first three trial wins went to the plaintiffs’ side and the last three to the defense.

“The jury’s verdict in favor of the company brings this trial to a successful conclusion and is consistent with the evidence in this case that Roundup does not cause cancer…” Bayer said in a statement.

May 11, 2022

Another legal blow to Bayer in Roundup litigation

The U.S. Solicitor General on Tuesday dealt a blow to Monsanto owner Bayer AG, advising the U.S. Supreme Court that it should deny the company’s request for a review of a key Roundup cancer trial loss.

Bayer has seen the Supreme Court as its last and best hope for putting a stop to the flood of lawsuits filed by tens of thousands of people claiming exposure to Roundup weed killing products caused them to develop non-Hodgkin lymphoma (NHL).

The brief from Solicitor General Elizabeth Prelogar states that “There is no sound reason for the Court to grant review…”

May 10, 2022

Guest column: Syngenta’s paraquat product kills weeds, but also people

By Jon Heylings

From 1986 until 2008, I worked as the lead scientist on a project aimed at creating a “safer” paraquat-based weed killing product for what was then known as the ICI Central Toxicology Laboratory, which became part of Syngenta AG in 2000.

April 14, 2022

California regulators changing language on glyphosate and cancer risk

The California Office of Environmental Health Hazard Assessment (OEHHA) is proposing changes to its messaging to consumers regarding the cancer risk associated with products made with the weed killing chemical glyphosate.

The language shift is subtle, but is significant for multiple reasons, including the potential for it to impact Monsanto’s efforts to appeal trial losses to the U.S. Supreme Court.